Own-Once Neuroplastic Pain Program

People with persistent pain demonstrably pay for mind-body retraining: Curable reports 1M+ users, 23k clinicians and an 82% improvement survey, and sells a $95.90/year subscription that is HSA/FSA-eligible (all company-reported and unaudited). The space is contested, not empty, as Curable, Pathways and PainApp all sell annual plans, so the wedge is the business model rather than the market. The recurring, opened complaints are specific: forced annual lock-in that a reviewer says Curable refused to reverse, a March 2026 reviewer noting "there's no free version whatsoever," an April 2026 billing/cancellation complaint, and Pathways buyers calling the price "unreal with only 60 lessons, many of which are less than 5 minutes" and wanting it "half as much." Because the content is a fixed library and Pathways already sells "access forever" at $79.00, a buy-once own-forever course at $39-$49 could undercut Curable's year-one price while removing renewal resentment; whether buyers want transcript/note-taking features is an interpretation, not directly documented (Curable ships transcripts, but no checked source shows buyers requesting them). Additional adjacent programs are pricier per PainApp's own page (Nerva about $199/year, DNRS about $350, Gupta about $499/year). Two cautions before believing it: the demand numbers are self-reported by the vendors, and Curable could add a cheap lifetime tier at any time.